It has been described, in agreement with our results, that antibodies against HCoVs did not correlate with cross-reactive CD4+ T-cells because they have not been recently generated, as observed with early CD4+ T-cell responses following yellow fever vaccination [14]. This evidence concerns the gene CD4 and viral infectious disease.